A. Lazar
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
- Genetics 21
- Inflammatory Bowel Disease 21
- Epidemiology 13
- Microscopic Colitis 12
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Edgar Schömig (3 shared papers)Albert Schömig (1 shared paper)Namhee Jung (1 shared paper)A. Kastrati (1 shared paper)Dirk Taubert (1 shared paper)Tobias Goeser (1 shared paper)Gundula Grimberg (1 shared paper)Uwe Fuhr (3 shared papers)
- Journals
- Journal of Crohn s and Colitis (11 papers)Gut (4 papers)Inflammatory Bowel Diseases (3 papers)Alimentary Pharmacology & Therapeutics (3 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
A. Lazar
25 papers receiving 894 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 126
- Cardiology and Cardiovascular Medicine 274
- Internal Medicine 33
- Genetics 211
- Endocrinology, Diabetes and Metabolism 95
Countries citing papers authored by A. Lazar
This map shows the geographic impact of A. Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lazar more than expected).
Fields of papers citing papers by A. Lazar
This network shows the impact of papers produced by A. Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lazar. The network helps show where A. Lazar may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lazar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 330 | |
| 2 | 2012 | 108 | |
| 3 | 2007 | 94 | |
| 4 | 2006 | 74 | |
| 5 | 2005 | 71 | |
| 6 | 2008 | 69 | |
| 7 | 2015 | 60 | |
| 8 | 2014 | 42 | |
| 9 | 2004 | 26 | |
| 10 | 1994 | 15 | |
| 11 | 2011 | 9 | |
| 12 | 2008 | 7 | |
| 13 | 2011 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 2012 | 2 | |
| 16 | 2014 | 2 | |
| 17 | 2014 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 1981 | 1 |
About A. Lazar
A. Lazar is a scholar working on Genetics, Epidemiology, Pediatrics, Perinatology and Child Health, Oncology and Hepatology, having authored 32 papers that have together received 925 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (21 papers), Microscopic Colitis (12 papers), Pharmaceutical studies and practices (5 papers), Adolescent and Pediatric Healthcare (3 papers), Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Pharmacology (126 citations), Cardiology and Cardiovascular Medicine (274 citations), Internal Medicine (33 citations), Genetics (211 citations) and Endocrinology, Diabetes and Metabolism (95 citations). A. Lazar has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Edgar Schömig, Albert Schömig, Namhee Jung, A. Kastrati, Dirk Taubert, Tobias Goeser, Gundula Grimberg, Uwe Fuhr, Dorota Tomalik‐Scharte and Dirk Gründemann. Their work appears in journals such as Journal of Crohn s and Colitis, Gut, Inflammatory Bowel Diseases, Alimentary Pharmacology & Therapeutics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.